Outlook Therapeutics Price Chart
Outlook Therapeutics Volume Chart
Outlook Therapeutics Market Segments
Overnight
-0.02(-1.92%)
| Open | $1.04 |
|---|---|
| Close | $1.02 |
| Low | $1.02 |
| Low Change | -0.02 (-1.92%) |
| High | $1.04 |
| High Change | +0.00 (+0.00%) |
| Range | $0.02 |
| Volume | 3.456K |
| Dollar Volume | $3.53K |
After Hours
+0.00(+0.01%)
| Open | $1.03 |
|---|---|
| Close | $1.03 |
| Low | $1.02 |
| Low Change | -0.01 (-0.97%) |
| High | $1.04 |
| High Change | +0.01 (+0.97%) |
| Range | $0.02 |
| Volume | 530.077K |
| Dollar Volume | $546.03K |
Regular Trading Hours
+0.01(+0.98%)
| Open | $1.02 |
|---|---|
| Close | $1.03 |
| Low | $0.97 |
| Low Change | -0.06 (-5.39%) |
| High | $1.06 |
| High Change | +0.04 (+3.92%) |
| Range | $0.10 |
| Volume | 8.88M |
| Dollar Volume | $9.15M |
Premarket
-0.01(-0.96%)
| Open | $1.04 |
|---|---|
| Close | $1.03 |
| Low | $0.98 |
| Low Change | -0.06 (-5.67%) |
| High | $1.08 |
| High Change | +0.04 (+3.85%) |
| Range | $0.10 |
| Volume | 505.391K |
| Dollar Volume | $520.55K |
After Hours Yesterday
+0.04(+4.15%)
| Open | $1.00 |
|---|---|
| Close | $1.04 |
| Low | $0.98 |
| Low Change | -0.02 (-2.24%) |
| High | $1.05 |
| High Change | +0.05 (+5.00%) |
| Range | $0.07 |
| Volume | 766.806K |
| Dollar Volume | $798.63K |
Regular Trading Hours Yesterday
+0.13(+14.64%)
| Open | $0.89 |
|---|---|
| Close | $1.02 |
| Low | $0.88 |
| Low Change | -0.00 (-0.28%) |
| High | $1.12 |
| High Change | +0.23 (+26.50%) |
| Range | $0.24 |
| Volume | 27.544M |
| Dollar Volume | $27.96M |
Premarket Yesterday
-0.01(-1.01%)
| Open | $0.89 |
|---|---|
| Close | $0.88 |
| Low | $0.83 |
| Low Change | -0.06 (-6.64%) |
| High | $0.90 |
| High Change | +0.01 (+1.12%) |
| Range | $0.07 |
| Volume | 231.114K |
| Dollar Volume | $203.61K |
Outlook Therapeutics News
4 days agoinvesting.comWhy is Outlook Therapeutics stock surging today?
- 2 months agoinvesting.com
Outlook Therapeutics stock surges on FDA BLA resubmission
- 2 months agoinvesting.com
Outlook Therapeutics stock surges after winning FDA appeal
- 7 months agoinvesting.com
Baidu, ASML, furniture stocks rise; Outlook Therapeutics sinks
- 7 months agoinvesting.com
Outlook Therapeutics stock plunges after FDA rejects wet AMD drug application
Outlook Therapeutics Top Trades
Outlook Therapeutics's top trade so far today returned +8.05%, while the top short trade returned -10.65%.
Outlook Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.08 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.23 |
| 20 Day Moving Average (SMA20) | $1.39 |
| 50 Day Moving Average (SMA50) | $1.19 |
| 100 Day Moving Average (SMA100) | $0.73 |
| 200 Day Moving Average (SMA200) | $0.94 |
Outlook Therapeutics Statistics
| Average Volume (30 Days) | 15.17M |
|---|---|
| P/E Ratio (Current) | -4.00 |
| EPS (Current) | -$0.25 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 0.20 |
| Current Ratio | 0.54 |
| Quick Ratio | 0.45 |
| Debt to Equity | -0.93 |
| Enterprise Value | $206.22M |
| EV to EBITDA | -4.78 |
| EV to Sales | 485.30 |
| Price to Book | -6.45 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 440.07 |
| Return on Assets | -2.18% |
| Return on Equity | 1.64% |
Outlook Therapeutics Stock Splits
There have been 2 stock splits for Outlook Therapeutics (OTLK). The last reverse stock split occured on March 14, 2024 and reduced the outstanding shares at a ratio of 20:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 14, 2024 | Reverse | 20:1 |
| Mar 18, 2019 | Reverse | 8:1 |
Outlook Therapeutics Dividends
There have been no dividends for Outlook Therapeutics (OTLK).